Table 2.
Description of sample/diagnosis |
Antigens |
||||||
Location |
α-SMA |
Shh |
|||||
Weak |
Moderate |
Strong |
Weak |
Moderate |
Strong |
||
Primary BCC |
Tumor |
627 (58.0%) |
274 (25.3%) |
181 (16.7%) |
347 (33.2%) |
344 (32.9%) |
355 (33.9%) |
Recurrent BCC |
195 (60.2%) |
52 (16.0%) |
77 (23.8%) |
96 (30.8%) |
101 (32.5%) |
114 (36.7%) |
|
Primary BCC |
Stroma |
914 (75.2%) |
216 (17.8%) |
85 (7.0%) |
929 (76.1%) |
223 (18.3%) |
68 (5.6%) |
Recurrent BCC |
243 (67.5%) |
60 (16.7%) |
57 (15.8%) |
259 (72.0%) |
67 (18.6%) |
34 (9.4%) |
α-SMA: Alpha-smooth muscle actin; BCC: Basal cell carcinoma; Shh: Sonic hedgehog. *The shown numerical data represent the number of visual fields estimated and demonstrated either weak or moderate and strong expression of antigen